A Global Multi-centre Observational Study in RA Patients Who Are Non Responders or Intolerant to a Single TNF Inhibitor.
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Rituximab (Primary) ; Tumour necrosis factor inhibitors
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 07 Jun 2017 Biomarkers information updated
- 01 Nov 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Mar 2012 New trial record